19th International Conference on Alzheimer's Drug Discovery

19th International Conference on Alzheimer's Drug Discovery is organized by Alzheimers Drug Discovery Foundation (ADDF) and will be held during Sep 17 - 18, 2018 at Hyatt Regency Jersey City, Jersey City, New Jersey, United States of America.

The purpose for this annual Alzheimer’s Drug Discovery Foundation (ADDF) conference is to accelerate the development of innovative treatments for Alzheimer’s disease, related dementias and cognitive aging.

Objectives :
• Highlight scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias.
• Increase networking opportunities for scientists to share information and resources.
• Foster interdisciplinary and public-private partnerships and alliances.

Audience :
Past attendees included:
• Academic and industry scientists engaged in drug discovery research for neurodegenerative diseases and CNS
• Business development and licensing professionals
• Alliance management professionals
• Venture capitalists and other investors
• Graduate students, PhD candidates and post-doctoral fellows

Attendees will see the diverse cutting-edge approaches ADDF scientists are undertaking and have opportunities for networking and partnership discussions with academic, industry, and foundation thought leaders.

Scholorships :
The Alzheimer’s Drug Discovery Foundation invites applications for the 2018 ADDF Young Investigator Scholarships. Ten scholarships will be presented. These prestigious scholarships recognize early achievements and seek to encourage the career development of the next generation of research scientists. Submissions are due July 1, 2018.

Additional details will be posted as soon as they are available.